Regaflo 5mg Tablet

Regaflo 5mg Tablet contains Solifenacin Succinate as its active ingredient. It belongs to a class of medications known as antimuscarinic agents or anticholinergics. Solifenacin is used to treat symptoms of overactive bladder (OAB), such as urinary urgency, frequency, and incontinence. It works by relaxing the muscles of the bladder, thereby reducing involuntary contractions and improving bladder control.

Uses:

Regaflo 5mg Tablet is prescribed for the treatment of overactive bladder (OAB) characterized by symptoms such as urinary urgency, frequency, and urge incontinence. It helps alleviate these symptoms by relaxing the muscles of the bladder, allowing for better control over urination. Regaflo 5mg Tablet is particularly beneficial for patients who have not responded adequately to non-pharmacological measures or lifestyle modifications.

Dosage:

The dosage of Regaflo 5mg Tablet is determined based on the individual patient’s response to treatment, medical history, and tolerability. It is usually taken orally once daily, with or without food, as directed by the healthcare provider. The tablet should be swallowed whole with a glass of water and not crushed, chewed, or divided. Patients should adhere to the prescribed dosage regimen to achieve optimal therapeutic effects.

Side Effects:

Common side effects associated with Regaflo 5mg Tablet may include dry mouth, constipation, blurred vision, urinary retention, and dizziness. These side effects are usually mild to moderate and transient, resolving with continued use or upon discontinuation of the medication. In some cases, more serious side effects such as allergic reactions, urinary tract infections, or elevated heart rate may occur. Patients should report any unusual or persistent side effects to their healthcare provider.

Precautions:

Before using Regaflo 5mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is essential to use caution in patients with urinary retention, gastrointestinal obstruction, or glaucoma. Solifenacin may interact with certain medications, so it’s crucial to review the patient’s medication regimen to prevent potential interactions.

When Not to Use:

Regaflo 5mg Tablet is contraindicated in patients with a known hypersensitivity to Solifenacin Succinate or any other components of the medication. It should not be used in patients with severe gastrointestinal conditions such as gastric retention, uncontrolled narrow-angle glaucoma, or urinary retention. Additionally, this medication is not recommended for use in patients with severe hepatic impairment.